Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2011 036 360.3 |
96 | EP file number | EAKZ | 15 16 4909.2 |
97 | EP publication number | EPN | 2923688 |
54 | Designation/title | TI | ANORDNUNG ZUR BENUTZERREKONSTITUTION |
51 | IPC main class | ICM (ICMV) | A61J 1/20 (2006.01) |
22 | DE application date | DAT | Aug 25, 2011 |
96 | EP application date | EAT | Aug 25, 2011 |
43 | Date of first publication | OT | Sep 30, 2015 |
| Date of publication of grant | PET | Mar 22, 2017 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP |
72 | Inventor | IN | Houghton, Frederick Charles ll, Moorpark, CA California 93021, US; Roush, Daniel E., Niles, IL Illinois 60714, US; Ariagno, Scott, Palatine, IL Illinois 60067, US |
74 | Representative | VTR | Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB, 80538 München, DE |
| Address for service | | Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB, 81633 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 376912 P Aug 25, 2010
|
| Due date | FT FG | Aug 31, 2026 Annual fee for the 16th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002923688 Searchable text:
EP000002923688 Original document:
EP000002923688B1 Searchable text:
EP000002923688B1 |
43 | Date of first publication | EVT | Sep 30, 2015 |
| Date of the first transfer into DPMAregister | EREGT | Oct 1, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 6, 2025 (Show all update days)(Hide all update days)- Aug 6, 2025
- Jun 7, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 22.03.2017: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 22.03.2017: deleted
- Jul 30, 2024
- Due date: changed
- Patent division in charge: changed
- Oct 1, 2015
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 4, 2021 |
| Issue number | HN | 28 |
| Year | PJ | 2021 |
| Publication date | VT | Jul 15, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Co. Ltd., Osaka, JP |
71/73 | Previous applicant/owner | INHF | Baxalta GmbH, Glattpark, Opfikon, CH, Baxalta Incorporated, Bannockburn, Ill., US |
| Date of update of the procedure | REGT | Jul 15, 2021 |